Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Exudative vitreoretinopathy Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 6 | 7 |
|
Comprehensive Vitreoretinopathy Panel PreventionGenetics, part of Exact Sciences United States | 26 | 21 |
|
Genomic Unity® Retinal Disorders Analysis Variantyx, Inc. United States | 1 | 394 |
|
CGC Genetics Unilabs Portugal | 1 | 203 |
|
CGC Genetics Unilabs Portugal | 1 | 306 |
|
CGC Genetics Unilabs Portugal | 1 | 223 |
|
Diseases of the posterior ocular segment (WES based NGS panel of 307 gene, including CNV analysis) CGC Genetics Unilabs Portugal | 1 | 307 |
|
Vitreoretinopathy (WES based NGS panel of 27 genes, including analysis of CNVs ) CGC Genetics Unilabs Portugal | 1 | 27 |
|
Mendelics Brazil | 1 | 321 |
|
MITOCHONDRIAL DISEASES PANEL (NUCLEAR GENES) Laboratorio de Genetica Clinica SL Spain | 1 | 1372 |
|
Genologica Medica Spain | 164 | 108 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Vitreoretinopathy panel. 23-gene NGS panel. Genologica Medica Spain | 63 | 23 |
|
Genomic Unity® Custom Analysis Variantyx, Inc. United States | 1 | 4054 |
|
Retinitis pigmentosa: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 75 | 71 |
|
Exudative vitreoretinopathy: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 7 | 6 |
|
Retinopathy and Optic Atrophy NGS Panel Fulgent Genetics United States | 563 | 241 |
|
Nonsyndromic Autosomal Recessive retinitis pigmentosa: gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 1 | 55 |
|
Retinitis Pigmentosa NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 103 | 92 |
|
Blueprint Genetics Finland | 1 | 260 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.